Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
HBM Healthcare Investments is a Swiss investment firm specializing in the global healthcare sector. Founded in 2001 and headquartered in Zug, it focuses on investing in private and public companies within biotechnology, medical technology, diagnostics, and human medicine. Approximately two-thirds of its assets are allocated to private companies, aiming for high value-creation potential. HBM Healthcare Investments is publicly traded on the SIX Swiss Exchange under the ticker HBMN
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is HBM Healthcare Investments' primary investment focus?
- HBM Healthcare Investments is a Swiss investment firm specializing in the global healthcare sector, focusing on biotechnology, medical technology, diagnostics, and human medicine. Approximately two-thirds of its assets are allocated to private companies.
- When was HBM Healthcare Investments founded and where is it headquartered?
- HBM Healthcare Investments was founded in 2001 and is headquartered in Zug, Switzerland.
- Is HBM Healthcare Investments a publicly traded entity?
- Yes, HBM Healthcare Investments is publicly traded on the SIX Swiss Exchange under the ticker HBMN.
- What is the range of investment amounts for HBM Healthcare Investments?
- HBM Healthcare Investments' investment range is between $10M and $200M.
- Can you name a notable recent investment by HBM Healthcare Investments?
- In July 2024, HBM Healthcare Investments invested $10,000,000 in Chemomab Therapeutics. Another notable investment was $75,000,000 in Fore Biotherapeutics in August 2023.
- Does HBM Healthcare Investments typically act as a lead investor in its funding rounds?
- According to startupim data, HBM Healthcare Investments has not been a lead investor in its recorded funding rounds.
- What is the total amount of managed assets by HBM Healthcare Investments?
- HBM Healthcare Investments manages $2 billion in assets.
- What sectors do HBM Healthcare Investments' portfolio companies primarily belong to?
- All of HBM Healthcare Investments' portfolio companies, such as Chemomab Therapeutics and Fore Biotherapeutics, are in the Health Tech & Life Sciences sector.
- When did HBM Healthcare Investments make its first recorded investment?
- HBM Healthcare Investments made its first recorded investment in September 2018.